X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-fanapt-iloperidone-receives-us-fda-approval-for-the-acute-treatment-of-bipolar-i-disorder-302106405.html
https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-the-publication-of-efficacy-and-safety-of-iloperidone-in-bipolar-mania-a-double-blind-placebo-controlled-study-in-the-journal-of-clinical-psychiatry-302037494.html
https://www.prnewswire.com/news-releases/fanapt-shown-to-be-effective-in-bipolar-i-disorder-in-phase-iii-clinical-study-301705863.html
https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-wins-key-us-supreme-court-patent-ruling-on-fanapt-300985926.html
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/11/news_detail_002844.jsp&mid=WC0b01ac058004d5c1
https://www.prnewswire.com/news-releases/vanda-receives-negative-opinion-for-marketing-authorization-from-the-european-medicines-agency-on-fanaptum-for-the-treatment-of-schizophrenia-300554039.html
http://www.raps.org/Regulatory-Focus/News/2017/07/21/28113/EMA-Backs-Eight-New-Medicines-Turns-Down-Drugs-From-Nektar--Vanda/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails
http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-settles-fanapt-patent-litigation-with-apotex-300374937.html
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207231
http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-settles-fanapt-patent-litigation-with-taro-300349897.html
http://www.prnewswire.com/news-releases/uspto-dismisses-petition-for-inter-partes-review-of-fanapt-patent-300320203.html
http://www.fiercepharmamarketing.com/story/fake-smiles-star-otsuka-and-lundbecks-dtc-push-rexulti-depression/2016-03-09
http://www.fiercepharma.com/story/allergan-and-richters-antipsychotic-gets-fda-ok-faces-stiff-competition/2015-09-17
http://www.prnewswire.com/news-releases/vanda-announces-fda-has-accepted-for-review-the-fanapt-supplemental-new-drug-application-for-maintenance-treatment-of-schizophrenia-in-adults-300142878.html
http://www.prnewswire.com/news-releases/vanda-announces-favorable-markman-ruling-in-fanapt-patent-infringement-litigation-300140758.html
Market Place
Share 
